In a world where precision drugs and personalized treatments present industry players with great opportunities and new challenges, the life sciences industry continues transforming itself to meet the future. These innovative treatments may cater to only a small patient population, but they offer tremendous value to the individuals receiving them.
Axtria’s Commercial Excellence Summit roundtable brought together pharmaceutical industry leaders to brainstorm ways to meet the current challenges of commercializing precision drugs and personalized medicines. They discussed key challenges and changes in commercialization strategy, organization design, and investment planning to align the industry for the future. These experts’ key takeaways follow:
We believe that by following these eight recommendations from this esteemed group, our industry can truly unlock the value in the precision medicine and personalized treatment space, enabling growth drivers for the future.